Cerus News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.03.24	Cerus: FDA Approves 12-month Shelf Life For INTERCEPT Platelet Processing Sets (RTTNews)
19.03.24	Cerus Announces Positive Results For Phase 3 Trial Of Intercept Blood System (RTTNews)
10.01.22	Cerus Preliminary 2021 Product Revenue To Exceed Its Guidance Range - Quick Facts (RTTNews)
03.11.21	Pre-market Movers: BBBY, RRD, GKOS, TMBR, IRTC… (RTTNews)
25.08.20	Pre-market Movers In Healthcare Sector: OCGN, CERS, IBIO, KMDA, SONN… (RTTNews)
07.07.20	Cerus Announces Inactivation Of SARS-CoV-2 With INTERCEPT Blood System For Plasma (RTTNews)
17.10.18	CERS Boosts Revenue Outlook, KOOL Hands Out Pink Slips, EIGR'S UTLRA Study Fails (RTTNews)
10.05.18	OPK Up 36% In 5 Days, SLDB Sparkles, CERS Abuzz, ARWR Expects Data In Nov. (RTTNews)
25.01.18	CARA Abuzz, CERS Up 20% In 5 Days, KURA Turns Heads, JNCE Making Iconic Moves (RTTNews)
24.01.18	AMRN Looks Forward To Big Event, PBYI Plunges After-hours, SPARC Lights Up CERS (RTTNews)
09.01.18	CBMG Up 90% In 5 Days, ALDR Delivers On Promise, ABLX Being Pursued By NVO (RTTNews)
29.08.17	Today's Research Report Coverage on Biotech Stocks -- Bellicum Pharma, Cara Therapeutics, Cerus, and Coherus Biosciences (PR Newswire)
03.08.17	Gainers & Losers Of Aug.2: ONCE, ILMN, XENT, NOVN, FLKS... (RTTNews)
06.07.17	Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM... (RTTNews)
08.06.17	Gainers & Losers Of June 7: NH, CRUS, PTCT, ANAB, ACRX... (RTTNews)
02.06.17	Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Cara Therapeutics, Cerus, and Concert Pharma (PR Newswire)
26.05.17	Gainers & Losers Of May 25: AERI, BCRX, NEOT, SNDX, SYRS... (RTTNews)
24.05.17	Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE... (RTTNews)
03.04.17	Research Reports Initiation on Biotech Stocks -- Alcobra, Cerus, 22nd Century, and Moleculin Biotech (PR Newswire)
31.01.17	Research Reports Initiation on Biotech Stocks -- Portola Pharma, Tesaro, Sangamo Therapeutics, and Cerus (PR Newswire)
19.12.16	Research Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Aralez Pharma, Cerus, and Pain Therapeutics (PR Newswire)
20.06.16	CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017 (RTTNews)
17.03.16	GLPG Awaits SAPHIRA Data, VTAE Vaults, CBLI Hits A Snag (RTTNews)
04.03.16	CERS Gets A Lift From Blood Bank Deal, VTAE On Track, TBRA Awaits Data In Q2 (RTTNews)
05.01.15	Cerus: EU Phase 3 Study Of INTERCEPT Red Blood Cells Meets Primary Endpoint (RTTNews)
22.12.14	Cerus U.S. Phase 2 Trial Of INTERCEPT Red Blood Cells Meets Primary Endpoint (RTTNews)
19.12.14	Cerus Surges As FDA Approves INTERCEPT Blood System For Platelets (RTTNews)
17.12.14	ASPX Flies On Trial Data, CYCC Knocked Down, NVGN Creates Buzz, BVX On Watch (RTTNews)
17.12.14	Cerus : FDA Oks Pathogen Reduction System To Treat Plasma (RTTNews)
21.11.14	Cerus: FDA Accepts IDE Supplement For INTERCEPT Blood System In Ebola Plasma (RTTNews)
07.10.14	Cerus Says FDA Accepts IDE Submission For INTERCEPT - Quick Facts (RTTNews)
01.08.14	ALXA Working Its Way, CERS Awaits FDA Decision, XNCR, SGEN Look Ahead To Results (RTTNews)
26.02.14	ANIK Needs Your Attention, DARA Gets A Double Blessing, ITMN ASCENDs So High (RTTNews)
02.10.13	ANAC, SLXP Get FDA Date, CERS On A High, MACK On Watch, OGEN And XON Team Up (RTTNews)
09.02.10	Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development (Businesswire)
14.01.10	Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets (Businesswire)
02.06.09	Cerus and Grifols to Collaborate on INTERCEPT Red Cell Kit Development (Businesswire)
24.02.09	Cerus Announces Marketing Authorization Granted to Largest Region of German Red Cross (Businesswire)
23.10.08	Bacterial Risks Prompt German Safety Measures (Businesswire)
29.01.07	Cerus' INTERCEPT Blood System Receives First Approval in Germany (Businesswire)
03.05.05	Cerus Corporation Announces First Quarter Financial Results (Businesswire)
19.04.05	Cerus to Present at American Association for Cancer Research Annual Me (Businesswire)
03.02.05	Cerus Corporation Announces Fourth Quarter and Year-End Results (Businesswire)
28.01.05	C. Raymond Larkin, Jr. Resigns from Cerus Board of Directors (Businesswire)
19.01.05	Cerus Corporation to Webcast Fourth Quarter and Year-End Financial Res (Businesswire)
05.01.05	Cerus and BioOne Sign Letter of Intent for Commercialization of INTERC (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	545.60	2.17 %	K V
Sika	235.80	1.51 %	K V
CieFinRichemont	127.65	1.43 %	K V
Part Grp Hldg	1’299.50	1.33 %	K V
Holcim	91.86	1.15 %	K V
Roche Hldg G	254.50	-0.66 %	K V
Lonza Grp	525.00	-0.72 %	K V
Sonova Hldg	297.70	-1.03 %	K V
Alcon	77.12	-1.20 %	K V
Swiss Life Hldg	690.40	-4.69 %	K V

mehr

03.12.24		Aufschläge in New York: NASDAQ Composite beendet den Handel mit Gewinnen
03.12.24		Zurückhaltung in New York: NASDAQ Composite zum Start leichter
02.12.24		NASDAQ-Handel: NASDAQ Composite liegt zum Start des Montagshandels im Plus
27.11.24		Schwacher Wochentag in New York: NASDAQ Composite verbucht zum Handelsstart Verluste
22.11.24		NASDAQ-Handel: NASDAQ Composite letztendlich fester
22.11.24		Starker Wochentag in New York: NASDAQ Composite am Nachmittag auf grünem Terrain
15.11.24		Schwacher Wochentag in New York: NASDAQ Composite präsentiert sich zum Start leichter
12.11.24		Minuszeichen in New York: NASDAQ Composite notiert am Nachmittag im Minus

03.12.24

Aufschläge in New York: NASDAQ Composite beendet den Handel mit Gewinnen

03.12.24

Zurückhaltung in New York: NASDAQ Composite zum Start leichter

02.12.24

NASDAQ-Handel: NASDAQ Composite liegt zum Start des Montagshandels im Plus

27.11.24

Schwacher Wochentag in New York: NASDAQ Composite verbucht zum Handelsstart Verluste

22.11.24

NASDAQ-Handel: NASDAQ Composite letztendlich fester

22.11.24

Starker Wochentag in New York: NASDAQ Composite am Nachmittag auf grünem Terrain